W. Cantrell, P. Lee, A. M. Mendelsohn, J. Parno, S. J. Rozzo, and W. Liao, “Efficacy and Safety of Tildrakizumab 100 Mg for Plaque Psoriasis in Patients Randomized to Treatment Continuation vs Treatment Withdrawal with Retreatment upon Relapse in Resurface 1”, J of Skin, vol. 4, no. 5, p. s40, Sep. 2020.